default author photo

Xizhi Wen

Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center

Guangzhou, 510060

China

SCHOLARLY PAPERS

3

DOWNLOADS

187

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Outlier Contrast Response to Anti-PD1 Treatment in Liver Metastasis of Uveal Melanoma Reveals Inducible Regulatory T Cell in Directing Anti-Tumor Immune Response

Number of pages: 28 Posted: 01 Oct 2020
Lujun Shen, Ying Wu, Han Qi, Jietian Jin, Fei Cao, Lin Xie, Shuanggang Chen, Yuanzhong Yang, Tao Huang, Ze Song, Qifeng Chen, Yinqi Zhang, Jinqing Mo, Dandan Li, Xizhi Wen, Xiaoshi Zhang and Weijun Fan
Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University (SYSU) - Department of Pathology, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, Sun Yat-sen University (SYSU) - Zhongshan School of Medicine, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy
Downloads 84 (777,583)

Abstract:

Loading...

Uveal Melanoma, iTreg, pembrolizumab, Differential Response, PRDM1

2.

Anti-Tumor Immune Response by Combining Cryoablation and Transarterial Infusion of Pembrolizumab (CATAP) for Liver Metastases of Melanoma

Number of pages: 34 Posted: 24 Sep 2019
Lujun Shen, Han Qi, Shuanggang Chen, Fei Cao, Lin Xie, Ying Wu, Ze Song, Hui Yuan, Tao Zhang, Dandan Li, Xizhi Wen, Qifeng Chen, Wang Li, Xiaoshi Zhang and Weijun Fan
Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Seventh Affiliated Hospital, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Intelligence Technology Co. Ltd, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy
Downloads 52 (1,041,696)

Abstract:

Loading...

Melanoma; Liver metastasis; Cryoablation; Pembrolizumab; Efficacy

3.

Bilirubin Restrains the Anticancer Effects of Vemurafenib on BRAF-Mutant Melanoma Cells via ERK-MNK1 Signaling

Number of pages: 27 Posted: 07 Apr 2021
Xiaoyu Zhong, Yufan Tan, Xizhi Wen, Leyi Yao, Zhenlong Shao, Wenshuang Sun, Jiawen Wu, Guanmei Wen, Daolin Tang, Xiaoshi Zhang, Yuning Liao and Jinbao Liu
Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, University of Texas at Dallas - Southwestern Medical Center, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Affiliated Cancer Hospital & Institute and Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation
Downloads 51 (1,052,702)

Abstract:

Loading...

bilirubin, vemurafenib, ERK, MNK1, BRAF-mutant melanoma